Monoclonal Antibody MG96 Completely Blocks Plasmodium yoelii Development in Anopheles stephensi

Rhoel R. Dinglasan, Iesha Fields, Mohammed Shahabuddin, Abdu F. Azad, John B. Sacci

Research output: Contribution to journalArticle

Abstract

In spite of research efforts to develop vaccines against the causative agent of human malaria, Plasmodium falciparum, effective control remains elusive. The predominant vaccine strategy focuses on targeting parasite blood stages in the vertebrate host. An alternative approach has been the development of transmission-blocking vaccines (TBVs). TBVs target antigens on parasite sexual stages that persist within the insect vector, anopheline mosquitoes, or target mosquito midgut proteins that are presumed to mediate parasite development. By blocking parasite development within the insect vector, TBVs effectively disrupt transmission and the resultant cascade of secondary infections. Using a mosquito midgut-specific mouse monoclonal antibody (MG96), we have partially characterized membrane-bound midgut glycoproteins in Anopheles gambiae and Anopheles stephensi. These proteins are present on the microvilli of midgut epithelial cells in both blood-fed and unfed mosquitoes, suggesting that the expression of the protein is not induced as a result of blood feeding. MG96 exhibits a dose-dependent blocking effect against Plasmodium yoelii development in An. stephensi. We achieved 100% blocking of parasite development in the mosquito midgut. Preliminary deglycosylation assays indicate that the epitope recognized by MG96 is a complex oligosaccharide. Future investigation of the carbohydrate epitope as well as gene identification should provide valuable insight into the possible mechanisms of ookinete attachment and invasion of mosquito midgut epithelial cells.

Original languageEnglish (US)
Pages (from-to)6995-7001
Number of pages7
JournalInfection and Immunity
Volume71
Issue number12
DOIs
StatePublished - Dec 2003
Externally publishedYes

Fingerprint

Plasmodium yoelii
Anopheles
Culicidae
Monoclonal Antibodies
Parasites
Vaccines
Insect Vectors
Epitopes
Epithelial Cells
Anopheles gambiae
Proteins
Falciparum Malaria
Microvilli
Coinfection
Oligosaccharides
Vertebrates
Glycoproteins
Carbohydrates
Antigens
Membranes

ASJC Scopus subject areas

  • Immunology

Cite this

Monoclonal Antibody MG96 Completely Blocks Plasmodium yoelii Development in Anopheles stephensi. / Dinglasan, Rhoel R.; Fields, Iesha; Shahabuddin, Mohammed; Azad, Abdu F.; Sacci, John B.

In: Infection and Immunity, Vol. 71, No. 12, 12.2003, p. 6995-7001.

Research output: Contribution to journalArticle

Dinglasan, Rhoel R. ; Fields, Iesha ; Shahabuddin, Mohammed ; Azad, Abdu F. ; Sacci, John B. / Monoclonal Antibody MG96 Completely Blocks Plasmodium yoelii Development in Anopheles stephensi. In: Infection and Immunity. 2003 ; Vol. 71, No. 12. pp. 6995-7001.
@article{e1af4c38716e434db1b689f36d8a515b,
title = "Monoclonal Antibody MG96 Completely Blocks Plasmodium yoelii Development in Anopheles stephensi",
abstract = "In spite of research efforts to develop vaccines against the causative agent of human malaria, Plasmodium falciparum, effective control remains elusive. The predominant vaccine strategy focuses on targeting parasite blood stages in the vertebrate host. An alternative approach has been the development of transmission-blocking vaccines (TBVs). TBVs target antigens on parasite sexual stages that persist within the insect vector, anopheline mosquitoes, or target mosquito midgut proteins that are presumed to mediate parasite development. By blocking parasite development within the insect vector, TBVs effectively disrupt transmission and the resultant cascade of secondary infections. Using a mosquito midgut-specific mouse monoclonal antibody (MG96), we have partially characterized membrane-bound midgut glycoproteins in Anopheles gambiae and Anopheles stephensi. These proteins are present on the microvilli of midgut epithelial cells in both blood-fed and unfed mosquitoes, suggesting that the expression of the protein is not induced as a result of blood feeding. MG96 exhibits a dose-dependent blocking effect against Plasmodium yoelii development in An. stephensi. We achieved 100{\%} blocking of parasite development in the mosquito midgut. Preliminary deglycosylation assays indicate that the epitope recognized by MG96 is a complex oligosaccharide. Future investigation of the carbohydrate epitope as well as gene identification should provide valuable insight into the possible mechanisms of ookinete attachment and invasion of mosquito midgut epithelial cells.",
author = "Dinglasan, {Rhoel R.} and Iesha Fields and Mohammed Shahabuddin and Azad, {Abdu F.} and Sacci, {John B.}",
year = "2003",
month = "12",
doi = "10.1128/IAI.71.12.6995-7001.2003",
language = "English (US)",
volume = "71",
pages = "6995--7001",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "12",

}

TY - JOUR

T1 - Monoclonal Antibody MG96 Completely Blocks Plasmodium yoelii Development in Anopheles stephensi

AU - Dinglasan, Rhoel R.

AU - Fields, Iesha

AU - Shahabuddin, Mohammed

AU - Azad, Abdu F.

AU - Sacci, John B.

PY - 2003/12

Y1 - 2003/12

N2 - In spite of research efforts to develop vaccines against the causative agent of human malaria, Plasmodium falciparum, effective control remains elusive. The predominant vaccine strategy focuses on targeting parasite blood stages in the vertebrate host. An alternative approach has been the development of transmission-blocking vaccines (TBVs). TBVs target antigens on parasite sexual stages that persist within the insect vector, anopheline mosquitoes, or target mosquito midgut proteins that are presumed to mediate parasite development. By blocking parasite development within the insect vector, TBVs effectively disrupt transmission and the resultant cascade of secondary infections. Using a mosquito midgut-specific mouse monoclonal antibody (MG96), we have partially characterized membrane-bound midgut glycoproteins in Anopheles gambiae and Anopheles stephensi. These proteins are present on the microvilli of midgut epithelial cells in both blood-fed and unfed mosquitoes, suggesting that the expression of the protein is not induced as a result of blood feeding. MG96 exhibits a dose-dependent blocking effect against Plasmodium yoelii development in An. stephensi. We achieved 100% blocking of parasite development in the mosquito midgut. Preliminary deglycosylation assays indicate that the epitope recognized by MG96 is a complex oligosaccharide. Future investigation of the carbohydrate epitope as well as gene identification should provide valuable insight into the possible mechanisms of ookinete attachment and invasion of mosquito midgut epithelial cells.

AB - In spite of research efforts to develop vaccines against the causative agent of human malaria, Plasmodium falciparum, effective control remains elusive. The predominant vaccine strategy focuses on targeting parasite blood stages in the vertebrate host. An alternative approach has been the development of transmission-blocking vaccines (TBVs). TBVs target antigens on parasite sexual stages that persist within the insect vector, anopheline mosquitoes, or target mosquito midgut proteins that are presumed to mediate parasite development. By blocking parasite development within the insect vector, TBVs effectively disrupt transmission and the resultant cascade of secondary infections. Using a mosquito midgut-specific mouse monoclonal antibody (MG96), we have partially characterized membrane-bound midgut glycoproteins in Anopheles gambiae and Anopheles stephensi. These proteins are present on the microvilli of midgut epithelial cells in both blood-fed and unfed mosquitoes, suggesting that the expression of the protein is not induced as a result of blood feeding. MG96 exhibits a dose-dependent blocking effect against Plasmodium yoelii development in An. stephensi. We achieved 100% blocking of parasite development in the mosquito midgut. Preliminary deglycosylation assays indicate that the epitope recognized by MG96 is a complex oligosaccharide. Future investigation of the carbohydrate epitope as well as gene identification should provide valuable insight into the possible mechanisms of ookinete attachment and invasion of mosquito midgut epithelial cells.

UR - http://www.scopus.com/inward/record.url?scp=0344420140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344420140&partnerID=8YFLogxK

U2 - 10.1128/IAI.71.12.6995-7001.2003

DO - 10.1128/IAI.71.12.6995-7001.2003

M3 - Article

C2 - 14638789

AN - SCOPUS:0344420140

VL - 71

SP - 6995

EP - 7001

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 12

ER -